Marta María
Alonso Roldán
Profesional Investigadora
University of Michigan–Ann Arbor
Ann Arbor, Estados Unidos
Publications in collaboration with researchers from University of Michigan–Ann Arbor (4)
2025
-
Author Correction: Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial(Nature Medicine, 10.1038/s41591-023-02347-y)
Nature Medicine
-
Paediatric strategy forum for medicinal product development in diffuse midline gliomas in children and adolescents ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration
European Journal of Cancer, Vol. 217
2024
2023
-
Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
Cancer Discovery, Vol. 13, Núm. 11, pp. 2370-2393